FDA PMA FDA Class 3 Approved 🇺🇸 United States

Automated Insulin Dosing Device System, Single Hormonal Control

PMA: P160017 · Supplement: S124 · Decision Aug 29, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P160017 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Automated Insulin Dosing Device System, Single Hormonal Control
Trade Name
MiniMed 780G System
PMA Number
P160017
Supplement Number
S124
Device Class
FDA Class 3
Product Code
OZP
Generic Name
Automated insulin dosing device system, single hormonal control
Medical Specialty
Unknown
Advisory Committee
Clinical Chemistry
Decision
Approved
Decision Code
APPR
Decision Date
August 29, 2025
Date Received
April 25, 2025
Supplement Type
Panel Track
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

Approval of the MiniMed 780G System for expanding the indications for use to include type 2 diabetes mellitus in persons 18 years of age and older requiring insulin.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OZP Automated Insulin Dosing Device System, Single Hormonal Control